The Curie Institute is a cancer research and care centre characterized by interdisciplinarity. The Cellular and Chemical Biology department cherishes this spirit by uniting within the same perimeter researchers from various backgrounds, notably organic chemistry and cell biology. It is our objective to address the timeliest challenges in life sciences and biomedicine from unique angles that become accessible due to a real integration between disciplines.
Exploiting iron chemistry to beat cancerThe work carried out at Institut Curie by Raphaël Rodriguez’ “Chemical Biology of Cancer” team revealed a new gateway to induce the death of cells with metastatic potential in connection with iron metabolism. Together with Marcus Conrad (Germany), the ferroptosis pioneer, and Stuart Schreiber (United States), father of modern chemical biology, they conceptualize new therapeutic approaches in an article that has just been published in the journal Molecular Cell.04/01/2022
More information to come.
Institut Curie Research Center
Institut Curie is a major player in the research and fight against cancer. It consists of a Hospital group and a Research Center of more than 1000 employees with a strong international representativeness. The objective of the Research Center is to develop basic research and to use this knowledge to improve the diagnosis, prognosis, and therapeutics of cancer as part of the continuum between basic research and innovation serving the patient.
Leibniz-Institute for Molecular Pharmacology (FMP)
The FMP is a non-university research institute and member of the Leibniz Association. The institute conducts basic research in molecular pharmacology and provides a vibrant, international and collaborative environment with state-of-the-art research facilities. The FMP belongs to the “Forschungsverbund Berlin e. V. (FVB)”, an institution of seven natural sciences research institutes in Berlin.